Prosecution Insights
Last updated: April 19, 2026

Osiris Therapeutics Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18696785 COMPOSITIONS OF DECIDUA TISSUE AND USES THEREOF TRUONG, QUANGLONG N 1615 Non-Final OA Mar 28, 2024
18584293 IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS VAN BUREN, LAUREN K 1638 Non-Final OA Feb 22, 2024
18043064 PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE KIM, TAEYOON 1631 Non-Final OA Feb 27, 2023
17854688 DISRUPTED CARTILAGE PRODUCTS GHALI, ISIS A D 1611 Final Rejection Jun 30, 2022
17401758 IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS VAN BUREN, LAUREN K 1638 Non-Final OA Aug 13, 2021

Managing Osiris Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month